EUVIMED · CrossrefZeitschrift
Molecular Neurodegeneration Advances
ISSN 3059-4944 · Springer Science and Business Media LLC
Neueste Artikel
Chimeric models of neurodegenerative diseases: from disease mechanisms to regenerative therapies
The role of lactate in Alzheimer’s disease: from controversies to therapeutic opportunities
The modifier matrix: emerging roles of ubiquitin-like proteins in Alzheimer’s disease
ApoE expression across the CNS: Who, What, Where, When, and How (much)?
Toward nanomedicine-enabled RNA therapeutics for Alzheimer’s disease
Neuroinflammatory stress preferentially impacts synaptic MAPK signaling and mitochondria in excitatory neurons
Pyk2 plays a critical role in synaptic dysfunction during the early stages of Alzheimer’s disease
Distinct CSF lipidomic profiles are associated with five proteomic subtypes in patients with Alzheimer’s disease
Differential downstream signaling in microglia lacking Alzheimer’s-related TREM2 or its adaptor TYROBP/DAP12
C3 lowering in adult APP KI mice rescues synapses and spares cognitive decline
Adoptive NK cell transfer confers neuroprotection by attenuating neuroinflammation and alpha-synuclein pathology in a mouse model of synucleinopathy
Uncovering plaque-glia niches in human Alzheimer’s disease brains using spatial transcriptomics
A new dawn in neurodegeneration research: MN advances
Dose-ranging and further therapeutic evaluation of a bicistronic humanized TrkB-BDNF gene therapy for glaucoma in rodents
The curious case of a heterozygous loss-of-function PSEN1 variant associated with early-onset Alzheimer’s disease
Emerging roles of the ciliary-mitochondrial axis in cellular homeostasis and neuroprotection
Genetics of PLCG2 expression and splicing relative to Alzheimer’s disease risk
Serum metabolomic-lipidomic signatures track long-term neurological performance in multiple sclerosis
Global C3 lowering in adulthood protects against hippocampal dysfunction and cognitive impairment in aged mice
Genetic evidence supports therapeutic modulation of progranulin levels in Alzheimer’s Disease
Divergent TDP43-regulated and TDP43-independent cryptic splicing in the cortex and spinal cord
Correction: Adoptive NK cell transfer confers neuroprotection by attenuating neuroinflammation and alpha-synuclein pathology in a mouse model of synucleinopathy
GPCRs with genetic associations to Alzheimer’s disease traits: an underdeveloped target class for disease progression
Development of cannabinoid-based therapies for Parkinson’s disease: emphasis on targeting cannabinoid receptors as CB2, PPAR-γ and GPR55 receptors
Lysosomal protease-mediated APP degradation is pH-dependent, mutation-sensitive, and facilitates tau proteolysis
Pretangle tau pathology accrual in the default mode network during the progression of Alzheimer’s disease
Spilling the T: T cells in tauopathy mechanisms, disease progression, and therapeutic horizons
The mechanism of actions of caffeine in Alzheimer’s disease: a systematic review of preclinical studies
Impaired microglial TYROBP/DAP12 signaling exacerbates cortical cholinergic and noradrenergic axonal degeneration in Aβ amyloidosis
Translating Alzheimer’s disease proteomics into drug discovery opportunities
EUVIMED